Imidol Tablet 25mg

Description

Indications 

Imidol Tablet 25mg is primarily indicated in conditions like Anorexia nervosa, Attention deficit disorders, Bulimia nervosa, Depression, Enuresis, Headache, Hyperactivity, Hypercalcaemia, Neuropathic pain, Neurosis, Obsessional states, Osteolytic lesions, Pain, Panic disorders, Phobias.

Side Effects 

The severe or irreversible adverse effects of Imidol Tablet 25mg, which give rise to further complications include Tachycardia, Oedema, Bundle branch blockage, Postural hypotension, Tachycardia., Imidol Tablet 25mg produces potentially life-threatening effects which include Agranulocytosis. which are responsible for the discontinuation of Imidol Tablet 25mg therapy., The signs and symptoms that are produced after the acute overdosage ofImidol Tablet 25mg include Hypotension, Tachycardia, Cardiac arrhythmias, Convulsions, Coma, Mydriasis, Hyperreflexia, Sinus tachycardia, hyperreflexia., The symptomatic adverse reactions produced by Imidol Tablet 25mg are more or less tolerable and if they become severe, they can be treated symptomatically, these include Drowsiness, Fatigue, Restlessness, Constipation, Abdominal pain, Dry mouth, Blurred vision, Urticaria, Photosensitivity, Impotence, Sleep disturbance, Hypotension, Weight gain, Tremor, Hepatotoxicity, Impairment of memory, Agitation, Cutaneous vasculitis, Eosinophilia, Loss of accomodation, Leukopenia, Urinary hesitancy, Urinary RetentionX, Urinary retention, Increased anxiety, Delayed ejaculation, Enlarged prostate gland, Dry mouth.

Contraindication 

Imidol Tablet 25mg is contraindicated in conditions like Epilepsy, Mania, Prostatic hypertrophy, Narrow-angle glaucoma,Bundle branch block, Post myocardial infarction, Hypersensitivity, Urinary retention.

Warning 

Imipramine HCl should be used with caution (if it contains tartrazine) in patients with aspirin hypersensitivity, because it may produce allergic reaction (including bronchial asthma). Monitor ECG before initiating large doses. Avoid concurrent administration with electric shock therapy because may increase the hazards of therapy. Perform periodic leukocytes (white blood cells) counts and liver function tests. Photosensitization may occur so caution patients to take protective measures sunscreen e.t.c. against exposure to UV light or sun light. Following prolong therapy in high doses, abrupt discontinuation should be avoided because it could precipitate the symptoms of cholinergic rebound such as nausea, vomiting and diarrhea. IM inj